Skip to main content
Livermore
Livermore
ZHEN

Wealthfront Advisers LLC

SEC CIK
0001763921
Latest filing
Aug 7, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Wealthfront Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
88,206
Value
$8.00M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Wealthfront Advisers LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202688,206$8.00M<0.1%−29,787−25.2%ReducedHolders
Q1 2026117,993$12.1M<0.1%−45,803−28.0%ReducedHolders
Q4 2025163,796$20.5M<0.1%+337+0.2%AddedHolders
Q3 2025163,459$21.9M0.1%−17,541−9.7%ReducedHolders
Q2 2025181,000$24.6M0.1%+19,231+11.9%AddedHolders
Q1 2025161,769$21.5M0.1%+22,966+16.5%AddedHolders
Q4 2024138,803$15.7M<0.1%+15,919+13.0%AddedHolders
Q3 2024122,884$14.0M<0.1%+12,329+11.2%AddedHolders
Q2 2024110,555$11.5M<0.1%−3,311−2.9%ReducedHolders
Q1 2024113,866$12.9M<0.1%+3,030+2.7%AddedHolders
Q4 2023110,836$12.2M<0.1%+16,083+17.0%AddedHolders
Q3 202394,753$9.18M<0.1%−62,865−39.9%ReducedHolders
Q2 2023157,618$17.2M0.1%+13,278+9.2%AddedHolders
Q1 2023144,340$14.6M0.1%−4,289−2.9%ReducedHolders
Q4 2022148,629$16.3M0.1%−18,024−10.8%ReducedHolders
Q3 2022166,653$16.1M0.1%+31,826+23.6%AddedHolders
Q2 2022134,827$14.6M0.1%−10,008−6.9%ReducedHolders
Q1 2022144,835$17.1M0.1%+3,473+2.5%AddedHolders
Q4 2021141,362$19.9M0.1%+21,778+18.2%AddedHolders
Q3 2021119,584$14.1M0.1%+16,421+15.9%AddedHolders
Q2 2021103,163$12.0M0.1%−7,955−7.2%ReducedHolders
Q1 2021111,118$13.3M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.